| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |